Past event: Digital Pharma Europe conference

Join us as we celebrate the 10th anniversary of Digital Pharma Europe, the leading educational platform for the European life sciences community!

In an effort to provide our most diverse pharmaceutical and medical device executive mix to date, this year's venue provides a centralized platform that is close to numerous UK pharma headquarters as well as Heathrow Airport. This will also allow for easy access to UK pharmaceuticals and medical device organizations and facilitate expedited travel time for European and US counterparts.

By bringing together over 200 life-science industry marketers, you will be able to employ a roadmap for a fully digitalized enterprise - no what your core business offering is


There are some exciting potential solutions on the horizon, but still many questions being asked:

  • How will digital disruption transform the pharma business model?
    Unlike other industries, the ''Uber'' of the pharma industry has yet to emerge, and the market remains ripe for digital disruption. Pharma companies are exploring how to transform through new business models to better engage their customers, and streamline their operations, and stay competitive.
  • How can pharma leverage digital and navigate digital trends and technologies to maximise positive outcomes for patients?
    Examining the adoption of digital across all industries is an important benchmarking process for pharma. Understanding how and why digital will impact healthcare and how patients can benefit is the key to developing successful and long-lasting engagement with your customer base. Therefore, identifying what a pharma company can do to address digital trends and emerging technologies is the first step in understanding what pharma companies will look like in future and preparing for this transition of your business.
  • How can pharma generate value from digital medicine solutions?
    As pharma companies shift from implementing traditional products to connected solutions, companies are challenged to define and realise value from this new business model (e.g., revenue stream) that intelligent digital medicine solutions require.
  • How can pharma engage with disruptive technologies?
    AI, AR, and cognitive computing are now a reality and are being used by doctors and physicians in predictive diagnostics. If we start to advance toward diagnostics from AI on a regular basis and take certain decisionmaking processes out of the doctors' hands, what are the implications for pharma marketing? How will brands and marketing teams adapt to this new world?
  • How can we demonstrate the value of digital for pharma products?
    Pharma companies are increasingly exploring the role that digital can play in demonstrating value through data, analytics, and real-world evidence.
  • How will pharma adapt to successfully engage HCPs?
    As HCPs evolve in their engagement with patients and how they manage their practice, pharma companies will have to transform their HCP-engagement approach.

We will explore these questions and more. Join the conversation and contribute to the advancement of digital health to improve patient outcomes and customer centricity! Reserve your seat for the 10th anniversary of the Digital Pharma Europe conference. We look forward to celebrating this milestone with you in London this May!


''What Exactly Will I Learn?''

Drive Optimized Marketing And Digital Operations, Launch Readiness And Marketing Capability By:
  • Establishing product launch excellence and launch models for multiple therapeutic categories
  • Measuring success in digital ROI and evaluating digital analytics
  • Global digital transformation
  • HCP user experience - user research -visualization and journey tools
  • Enhancing commercial planning quality by increasing alignment among Marketing, Medical, Finance & Sales functions
  • Improve the overall quality of strategic brand plans across BUs by developing a more patient-centric approach and delivering innovation in patient centricity
  • Grow e-SOV for your brands by:
    - Leveraging HCP portals across the globe - how to lead from strategy into deployment across high numbers of markets
    - Digital engagement and programming for HCPs, 360 views, etc.
    - Developing market-leading content strategy and targeting around e-mail magazines and Veeva approved e-mails
    - Execute successful webcasts
  • Improve handling of marketing material and increased i-detailing usage to increase rep call quality and sales
  • The evolving tools and tactics of digital to improve patient quality of life and outcomes, e.g. AI and remote diagnostics
  • Omnichannel optimization - identifying the optimal channel mix, timing of digital and sales visit that lead to drug adoption
  • Optimized content production through the set up of a new asset management process
  • Real world data - how this applies to pharma and can provide a better understanding of the patient.
  • Role of AI in pharma - Can AI help with predictive marketing?
  • Optimizing remote promotion, remote detailing and virtual promotion
  • Utilization of the marketing automation system to optimize digital marketing tactics to generate leads
  • Differences in Agency vs. Corporate life and ways-of-working (Working with Agencies)

Speakers

  • Claudia Adreani, Digital Lead – UK, ASTRAZENECA, UK
  • Prof. Shafi Ahmed, Chief Medical Officer, MEDICAL REALITIES
  • Diego Boado, Digital Strategy Manager, SHIRE
  • Sari Carter, Digital Strategist, ANTHILL AGENCY
  • Claudio Cipriani, Customer Engagement Director, MSD, ITALY
  • Robert Gargiulo, (Founding) Director of Marketing, Mylan Consumer Healthcare, MYLAN, USA
  • Jalilah Gibson, Global Digital Channels Lead, GLAXOSMITHKLINE
  • Michel Girault, Global Multichannel Marketing Lead, VIFOR PHARMA, SWITZERLAND
  • Uri Goren, Digital Experience Lead – Pharma Innovative Solutions, TEVA PHARMACEUTICALS, ISRAEL
  • Shwen Gwee, Head of Digital Strategy, Global Clinical Operations, BIOGEN, USA
  • Paul Hartigan, CEO, PHARMIWEB SOLUTIONS, UK,USA
  • Garth Hemmingsen, Global Patient Services Lead – Technology Solutions, SHIRE, SWITZERLAND
  • Prof. Rowlan Iling, DM MRCS FRCR, Chief Marketing Officer, AFFIDEA
  • Philippe Kirby, Director, Customer Engagement Capabilities, MSD INTERNATIONAL GMBH, SWITZERLAND
  • Dr. Mukund KS, Associate Director, IT (Emerging Markets), Head CRM, DR. REDDY'S LABORATORIES, INDIA
  • John Lineen, Global Digital Director, Global Commercial Strategies and Platforms, GLAXOSMITHKLINE, USA
  • Cyril Mandry, Multichannel Marketing Director, MSD, SWITZERLAND
  • Syed Umair Maroof, GM – Digital Marketing., Marketing Manager — Ortho and Primary Care, PHARMEVO, PAKISTAN
  • Anoo Mehmi, Global Digital Content Strategist, VIIV HEALTHCARE, UK
  • Hiromasa Mori, Head of Neurology Patient Technology, Europe, UCB PHARMACEUTICALS, BELGIUM
  • Danilo Pagano, Head of Global Customer Interaction Management, LUNDBECK, DENMARK
  • Andreas Panteli, Digital Insights and Measurement Manager, NOVARTIS, SWITZERLAND
  • Panos Papakonstantinou, Head of Digital Commercial, Region Europe, NOVARTIS, SWITZERLAND
  • János Pénzes, M.D., International eMarketing Manager, International Marketing, GEDEON RICHTER, HUNGARY
  • Paul Reynolds, Associate Vice President at Allergan, Head of Specialty Care and Established Brands (International), ALLERGAN, UK
  • Parker Richardson, Director, Digital Asset Management and Approval Program, GLAXOSMITHKLINE
  • Igor Rudychev, Global Samples Operations Lead, PFIZER, USA
  • Milena Saleh, Global Director, Digital Health, SANOFI, GERMANY
  • Dr. Selim Sariyerli, Global CRM and Digital Analytics Manager, FERRING PHARMACEUTICALS, SWITZERLAND
  • Guy Shauli, Global Director, Social Media, ASTRAZENECA, UK
  • Mauricio Campos Suarez, EEMEA Regional IT Director, MSD, SWITZERLAND
  • Neil Williams, Director Front-End Innovation – Head of Connected Health, MEDICOM INNOVATION PARTNER LTD.
 A PHILLIPS-MEDISIZE
  • Jeff Wray, Director, Europe and APAC Research, DRG DIGITAL - MANHATTAN RESEARCH, UK
  • Natalie Yeadon, Co-Owner and Managing Director, IMPETUS DIGITAL

Please fill in your name and email to receive the conference agenda of this event.


Disruptive Technologies/Social Innovation Day - 9 May 2018

Main Conference Day One - 10 May 2018

Main Conference Day Two
- 11 May 2018

The agenda is available as PDF under downloads at the right side of the page.

Venue

The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.

Venue

Radisson Blu Edwardian, Heathrow
140 Bath Road
Hayes, Middlesex UB3 5AW
+ 44 (0) 20 3856 3961

To make reservations please call + 44 (0) 20 3856 3961 and request the negotiated rate for ExL's 8th Digital Pharma Europe. T make reservations online Click Here

The group rate is available until 17 April 2017. Please book your room early, as rooms available at this rate are limited.
Event details
Organizer : ExL
Event type : Conference
Reference : ASDE-18637